Idarubicin Plus Cytarabine (IA) vs IA Plus Cladribine (IAC) as Induction Regimen to Treat Initially Diagnosed Acute Myeloid Leukemia (AML)
Clinical trial NCT02323022 · COMPLETED
Trial details
- NCT number
- NCT02323022
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2020-03-01
- Enrollment
- 618
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.